Anti-glypican 3 antibodies
PH12024550858B1Active Publication Date: 2026-07-03LEPU BIOPHARMA CO LTD
0 Cites 0 Cited by
Patent Information
- Authority / Receiving Office
- PH · PH
- Patent Type
- Patents
- Current Assignee / Owner
- LEPU BIOPHARMA CO LTD
- Filing Date
- 2024-04-08
- Publication Date
- 2026-07-03
Abstract
This disclosure provides anti-GPC3 antibodies, including murine antibodies, humanized antibodies, and those with further optimized CDR sequences. The newly disclosed antibodies exhibited higher cell-based binding efficiency than the leading anti-GPC3 antibody candidate under clinical development.
Need to check novelty before this filing date? Find Prior Art